Dana Farber Cancer Center to Retract or Fix Dozens of Studies
TUESDAY, Jan. 23, 2024 (HealthDay News) — The prestigious Dana Farber Cancer Institute in Boston will retract six studies and correct 31 more as part of an ongoing investigation into claims of data manipulation. The action follows allegations that a British molecular biologist posted in a blog earlier this month suggestingContinue Reading